News

Bill C-64 An act respecting pharmacare was passed on October 10. In a new blog post, CPhA’s Dave Penner, Director of Advocacy and Policy, explains what happens next.

In a new blog post, CPhA’s new chair, Annette Robinson, shares an update on CPhA’s current advocacy priorities and what we’re focused on through the final quarter of 2024. From pharmacare and third-party payer advocacy to evolving the CPS, we’re staying on top of the issues that make a difference for you and your patients.

With the recent World Health Organization (WHO) declaration of mpox as a global public health emergency of international concern and increasing media coverage, pharmacy professionals may be getting more questions at the pharmacy counter about the virus.

The Indigenous Pharmacy Professionals of Canada (IPPC), in partnership with the Canadian Pharmacists Association (CPhA), is thrilled to announce the 2024-25 recipients of the IPPC Indigenous Pharmacy Scholarship.

NIAM is an annual event in August that highlights the importance of staying up to date on recommended vaccinations so that everyone can have the chance to live healthier lives protected against preventable diseases.

This year CPhA hosted a reception in Halifax, Nova Scotia, and met premiers from almost every province. Without fail, every single premier and staff person we met commented on the increased role that pharmacists have played in primary care.

Pharmacists are well-positioned to act as environmental stewards and help mitigate the environmental harms associated with our health-care system. Here’s a round-up of some helpful resources to support you in promoting environmental sustainability in your pharmacy and with your patients and colleagues. 

This past February, the federal Minister of Health, the Hon. Mark Holland, introduced Bill C-64 in the House of Commons. Bill C-64, An Act respecting pharmacareproposed a universal, single-payer system that would provide Canadians with access to 2 specific drug classes: contraception and diabetes. Recognizing that provinces and territories currently provide access to public drug plans, the Bill seeks to establish a framework through which the federal government can provide fundingto the provinces and territories to implement the proposed pharmacare program.